CBGL (Cannabis Global) Market Cap: $0.66 Mil (As of Jun. 25, 2026)


What is Cannabis Global Market Cap?

Cannabis Global CBGL Market Cap is $0.66 Mil as of Jun. 25, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cannabis Global's share price for the quarter that ended in May. 2022 was $0.003. Cannabis Global's Shares Outstanding (EOP) for the quarter that ended in May. 2022 was 553.14 Mil. Therefore, Cannabis Global's market cap for the quarter that ended in May. 2022 was $1.66 Mil.

Cannabis Global's quarterly market cap increased from Nov. 2021 ($1.56 Mil) to Feb. 2022 ($1.73 Mil) but then declined from Feb. 2022 ($1.73 Mil) to May. 2022 ($1.66 Mil).

Cannabis Global's annual market cap declined from Aug. 2019 ($8.42 Mil) to Aug. 2020 ($3.25 Mil) and declined from Aug. 2020 ($3.25 Mil) to Aug. 2021 ($3.02 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cannabis Global's Enterprise Value for Today is $0.66 Mil.


Cannabis Global  (OTCPK:CBGL) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Cannabis Global Market Cap Related Terms


Cannabis Global Market Cap Historical Data

* Premium members only.

The historical data trend for Cannabis Global's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabis Global Market Cap Chart

Cannabis Global Annual Data
Trend Aug12 Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 3.68 8.42 3.25 3.02

Cannabis Global Quarterly Data
Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.31 3.02 1.56 1.73 1.66

CBGL vs MILC, BBBT, GCAN: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Global's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Global Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Global's Market Cap distribution charts can be found below:

* The bar in red indicates where Cannabis Global's Market Cap falls into.



Cannabis Global Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Cannabis Global's Market Cap for the fiscal year that ended in Aug. 2021 is calculated as

Market Cap (A: Aug. 2021 )=Share Price (A: Aug. 2021 )*Shares Outstanding (EOP) (A: Aug. 2021 )
=$0.0355*84.940
=$3.02

Cannabis Global's Market Cap for the quarter that ended in May. 2022 is calculated as

Market Cap (Q: May. 2022 )=Share Price (Q: May. 2022 )*Shares Outstanding (EOP) (Q: May. 2022 )
=$0.003*553.143
=$1.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.66 Mil mean?
Cannabis Global (CBGL) has a Market Cap of $0.66 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cannabis Global and its competitors.
Is Cannabis Global's Market Cap too high?
Cannabis Global's current Market Cap is $0.66 Mil. The Drug Manufacturers industry median Market Cap is 206.50. Cannabis Global's value of $0.66 Mil is 99.7% below this industry median.
How does Cannabis Global's Market Cap compare to MILC and BBBT?
Cannabis Global's Market Cap of $0.66 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 206.50. Cannabis Global's value of $0.66 Mil is 99.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 206.50, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannabis Global's current Market Cap of $0.66 Mil is 99.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cannabis Global and its competitors. For the Drug Manufacturers industry, the median Market Cap is 206.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabis Global's current Market Cap is $0.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Global stock overvalued right now?
Cannabis Global (CBGL) has a current Market Cap of $0.66 Mil. The current Market Cap is $0.66 Mil and 99.7% below the Drug Manufacturers industry median of 206.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cannabis Global (CBGL), the current Market Cap is $0.66 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabis Global Business Description

Address 520 S Grand Avenue, Suite 320, Los Angeles, CA, USA, 90071
Cannabis Global Inc manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.